Daniel Verduzco
Papers
2
Total Citations
12
H-Index
2
About
Daniel Verduzco is an emerging researcher specializing in CRISPR-based genomic screening technologies, with a focus on optimizing tools for large-scale functional genomics. His most notable contribution centers on advancing genomewide loss-of-function (LOF) screening methodologies, particularly through the innovative application of AsCas12a and multi-guide arrays as alternatives to conventional CRISPR-Cas9 systems. By addressing key limitations inherent in traditional genomewide CRISPR libraries, Verduzco's work has helped push the boundaries of what is achievable in high-throughput gene discovery across both physiological and pathophysiological contexts. His primary publication on this topic, "Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays," has garnered 10 citations since its 2023 release, reflecting growing interest from the research community in more efficient and reliable screening platforms. An earlier preprint version from 2022 has also drawn attention, further demonstrating the timeliness and relevance of his contributions. For students and researchers working at the intersection of functional genomics, gene editing, and disease biology, Verduzco's work represents a meaningful step forward in the toolkit available for uncovering novel gene functions at scale.
Research Focus
Key Achievements
Top Papers
- 1
- 2